DarioHealth Corp. DRIO
DarioHealth Corp. (Nasdaq: DRIO) is a cardio-renal-metabolic medical device company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| Dario Smart Diabetes Management Solution (glucose monitoring system and software) | Diabetes | unclear | NA_NON_THERAPEUTIC |
| Wireless blood pressure monitor and software | Hypertension | unclear | NA_NON_THERAPEUTIC |
| Twill prescription digital therapeutic (Breakthrough Device Designation) | Behavioral health | unclear | NA_NON_THERAPEUTIC |
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other cardio-renal-metabolic companies
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.